Librofem (Ibuprofen Bp)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, ibuprofen reduces inflammation, diminishes pain‑signal transmission, and resets the hypothalamic thermostat that controls body temperature.

The appropriate dose of Librofem is determined by a qualified prescriber based on the patient’s age, weight, clinical condition, and response to therapy. Healthcare professionals consider the lowest effective dose for the shortest duration needed to achieve therapeutic goals.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester because of potential fetal complications, and caution is advised during the first two trimesters. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the Librofem product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both ibuprofen (Librofem) and naproxen belong to the NSAID class and share similar mechanisms of COX inhibition. Ibuprofen generally has a shorter half‑life, which may require more frequent dosing, while naproxen offers a longer duration of action. Choice between them depends on patient‑specific factors, tolerability, and physician preference.

Librofem should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keeping the tablets in a dry, cool place helps maintain potency and prevents degradation.

Librofem is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with food can reduce the likelihood of stomach upset. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, hepatotoxicity, and an increased chance of cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use. Patients should seek immediate medical attention if they notice signs of these conditions.

Librofem should not be used by individuals with a known hypersensitivity to ibuprofen or any NSAID, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and anyone in the third trimester of pregnancy. Consultation with a healthcare professional is essential before starting therapy.